Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Seegene Inc And Eisai Co., Ltd's Eidia Collaborate To Bring New Multiplex Molecular Diagnostic Tests To Japan


Monday, 1 Jul 2013 08:03am EDT 

Seegene Inc announced that it has entered into a collaboration agreement with Eidia, the in vitro diagnostics subsidiary arm of Eisai Co., Ltd. Through this agreement, Eidia gains access to Seegene's portfolio of TOCE technology-based multiplexed molecular diagnostic (MoDx) tests for the Japanese diagnostic test market. Under the terms of the agreement, Seegene will supply a wide range of TOCE technology-based multiplexed molecular diagnostic tests, and Eidia will exclusively market and distribute them in Japan. In addition, Eidia will be responsible for obtaining regulatory clearance from the Japanese Pharmaceutical and Medical Device Agency. 

Related Company News

Company Quote

4322.5
-31.5 -0.72%
2:00am EDT